Amicus Therapeutics, Inc. (FOLD) Social Stream



Amicus Therapeutics, Inc. (FOLD): $10.65

0.06 (-0.56%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add FOLD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#55 of 359

in industry

AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AMICUS THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $29 $12 $18 $13.35 34.83%
2021-11-15 10 $29 $12 $18.444 $13.35 38.16%
2021-11-23 10 $29 $12 $18.555 $13.35 38.99%
2022-01-13 9 $29 $12 $17.375 $13.35 30.15%
2022-01-17 9 $29 $15 $17.875 $13.35 33.9%
2022-01-26 9 $29 $15 $17.5 $13.35 31.09%
2022-02-25 9 $29 $14 $17 $13.35 27.34%
2022-04-20 9 $20 $14 $15.5 $13.35 16.1%
2022-05-10 10 $20 $11 $15 $13.35 12.36%
2022-05-12 8 $20 $11 $15.125 $13.35 13.3%
2022-08-05 7 $20 $11 $15 $13.35 12.36%
2022-08-13 7 $20 $11 $15.142 $13.35 13.42%
2022-10-19 8 $20 $11 $15 $13.35 12.36%
2022-11-07 8 $20 $11 $15.125 $13.35 13.3%
2022-11-15 8 $20 $11 $15.428 $13.35 15.57%
2023-01-16 8 $20 $11 $15.375 $13.35 15.17%
2023-02-08 8 $20 $11 $15.875 $13.35 18.91%
2023-03-03 9 $20 $11 $16.111 $13.35 20.68%
2023-04-12 9 $20 $11 $16.222 $13.35 21.51%
2023-07-11 8 $20 $11 $16.111 $13.35 20.68%
2023-08-09 8 $20 $11 $16.222 $13.35 21.51%
2023-08-10 8 $20 $11 $16.333 $13.35 22.34%
2023-09-26 8 $20 $11 $16.444 $13.35 23.18%
2023-09-29 8 $20 $11 $16.555 $13.35 24.01%
2023-09-30 8 $21 $11 $17.555 $13.35 31.5%
2023-11-08 8 $21 $11 $17.444 $13.35 30.67%
2023-11-10 8 $21 $11 $17.777 $13.35 33.16%
2023-11-29 8 $21 $11 $18 $13.35 34.83%
2023-12-14 9 $21 $14 $18.333 $13.35 37.33%
2023-12-19 9 $21 $14 $18.888 $13.35 41.48%

The Trend in the Analyst Price Target


Over the past 43 months, FOLD's average price target has gone up $0.57.

FOLD reports an average of 39.01% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 8 20 11 15.875 12.58 26.19%
2023-04-11 9 20 11 16.222 11.20 44.84%
2023-05-12 8 20 11 16.111 11.29 42.7%
2023-09-26 8 20 11 16.444 12.24 34.35%
2023-09-29 8 20 11 17.000 12.16 39.8%

FOLD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.22 8 0 1 0 0 9

The Trend in the Broker Recommendations


FOLD's average broker recommendation rating improved by 0.03 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FOLD as an investment opportunity.

  • In the context of all US stocks, AMICUS THERAPEUTICS INC's average analyst price target is higher than 758.73% of them.
  • In terms of how AMICUS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2503.54% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 945.35% of them.
  • In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is higher than 2231.01% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are ENTA, MDGL, and MGNX.

Make investment decisions regarding FOLD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!